No abstract

MI (mitral insufficiency) is the most common valvulopathy currently, with surgery being the gold standard treatment. However, about half of patients with severe MI have a high surgical risk because of their age or comorbidities, therefore surgery is contraindicated. In this context, Mitraclip® appears, a device that allows the percutaneous treatment of MI and which is presented as a safe alternative and able to improve the quality of life for these patients. This work describes the first procedure performed at a referral hospital in western Paraná-Brazil. It is a male patient with mitral valve insufficiency due to mitral prolapse, submitted to endovascular therapy due to the high surgical risk because of his advanced age, presence of comorbidities and left ventricular dysfunction. From this modality, partial regurgitation improvement and intense symptomatic relief were obtained, demonstrating the great potential of the MitraClip® device to improve the quality of life of its patients.

No abstract

No abstract

No abstract